Musculoskeletal disorders in diabetes mellitus

Revista Brasileira de Reumatologia

Volumn 52, Issue 4, 2012, Pages 601-605

  Silva, Marilia Barreto Gameiro ^a   Skare, Thelma Larocca ^a  

^a Operative Technique and Experimental Surgery Laboratory   (Brazil)

Author keywords

Bursitis; Carpal tunnel syndrome; Diabetes mellitus; Dupuytren's contracture; Trigger finger

Indexed keywords

ALENDRONIC ACID; ANALGESIC AGENT; CALCITONIN; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID;

ARTICLE; BACTERIAL ARTHRITIS; CARPAL TUNNEL SYNDROME; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DUPUYTREN CONTRACTURE; GLUCOSE BLOOD LEVEL; HUMAN; HUMEROSCAPULAR PERIARTHRITIS; HYPERGLYCEMIA; HYPEROSTOSIS; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; JOINT LIMITATION; MUSCLE DISEASE; MUSCULAR INFARCTION; MUSCULOSKELETAL DISEASE; NEUROPATHIC JOINT DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; PHYSIOTHERAPY; QUALITY OF LIFE; SIDE EFFECT; SPLINTING; STIFF HAND SYNDROME; TENDINITIS; TENOSYNOVITIS; TRIGGER FINGER;

DIABETES COMPLICATIONS; HUMANS; MUSCULOSKELETAL DISEASES;

EID: 84866523639     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042012000400010     Document Type: Article

References (72)

1. Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med 2003; 37 (1): 30-5.
2. Alvin C Power. Diabetes mellitus. In: Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D Jameson JL (eds.). Harrison's Principle of Internal Medicine. 16.ed. McGraw-Hill, 2004; pp. 3779-829.
3. Lebiedz-Odrobina D, Kay J. Rheumatic manifestation of diabetes mellitus. Rheum Dis Clin N Am 2010; 36 (4): 681-99.
4. Savas S, Köroǧlu BK, Koyuncuoǧlu HR, Uzar E, Celik H, Tamer NM. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007; 77 (1): 77-83.
5. Arkkila PE, Gautier JF. Musculoskeletal disorders in diabetes mellitus: an update. Best Pract Res Clin Rheumatol 2003; 17 (6): 945-70.
6. Burner TW, Rosenthal AK. Diabetes and rheumatic diseases. Cur Opin Rheumatol 2009; 21 (1): 50-4.
7. Crispin JC, Alcocer-Varela J. Rheumatic manifestations of diabetes mellitus. Am J Med 2003; 114 (9): 753-7.
8. Kapoor A, Sibbitt WL Jr. Contractures in diabetes mellitus: the syndrome of limited joint mobility. Semin Arthritis Rheum 1989; 18 (3): 168-80.
9. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991; 87 (2): 432-8.
10. Traisman HS, Traisman ES, Marr TJ, Wise J. Joint contractures in patients with juvenile diabetes and their siblings. Diabetes Care 1978; 1 (6): 360-1.
11. Rosembloom AL, Silverstein JH, Riley WJ, Maclaren NK. Limited joint mobility in childhood diabetes: family studies. Diabetes Care 1983; 6 (4): 370-3.
12. Yosipovitch G, Loh KC, Hock OB. Medical pearl: Scleroderma-like skin changes in patients with diabetes mellitus. J Am Acad Dermatol 2003; 49 (1): 109-11.
13. Seibold JR. Digital sclerosis in children with insulin-dependent diabetes mellitus. Arthritis Rheum 1982; 25 (11): 1357-61.
14. Kuryliszyn-Moskal A, Dubicki A, Zarzycki W, Zonnenberg A, Górska M. Microvascular abnormalities in capillaroscopy correlate with higher serum IL-18 and sE-selectin levels in patients with type 1 diabetes complicated by microangiopathy. Folia Hystoch Cytobiol 2011; 49 (1): 104-10.
15. Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Engl J Med 1981; 305 (4): 191-4.
16. Fitzcharles MA, Duby S, Wadell RW, Banks E, Karsh J. Limitation of joint mobility (cheiroarthropathy) in adult with noninsulin-dependent diabetic patients. Ann Rheum Dis 1984; 43 (2): 251-4.
17. Arkilla PE, Kantola IM, Vikari JS, Rönnemaa T, Vähätalo MA. Limited joint mobility is associated with the presence but does not predict the development of microvascular complication in type 1 diabetes. Diabet Med 1996; 13 (9): 828-33.
18. Ardic F, Soyupek F, Kahraman Y, Yorgancioglu R. The musculoskeletal complications seen in type II diabetics: predominance of hand involvement. Clin Rheumatol 2003; 22 (3): 229-33.
19. Chammas M, Bousquet P, Renard E, Poirier JL, Jaffiol C, Allieu Y. Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am 1995; 20 (1): 109-14.
20. Noble J, Heathcote JG, Colen H. Diabetes mellitus in the aetiology of Dupuytren's disease. J Bone Joint Surg Br 1984; 66 (3): 322-5.
21. Hart MG, Hooper G. Clinical associations of Dupuytren's disease. Postgrad Med J 2005; 81 (957): 425-8.
22. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009; 361 (10): 968-79.
23. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med 2002; 112 (6): 487-90.
24. Yosipovitch G, Yosipovitch Z, Karp M, Mukamel M. Trigger finger in young patients with insulin dependent diabetes. J Rheumatol 1990; 17 (7): 951-2.
25. Kameyama M, Meguro S, Funae O, Atsumi Y, Ikegami H. The presence of limited joint mobility is significantly associated with multiple digit involvement by stenosing flexor tenosynovitis in diabetics. J Rheumatol 2009; 36 (8): 1686-90.
26. Koh S, Nakamura S, Hattori T, Hirata H. Trigger digits in diabetes: their incidence and characteristics. J Hand Surg Eur Vol 2010; 35 (4): 302-5.
27. Nashel DJ. Entrapment neuropathies. In: Klippel JH, Dieppe PA (eds.). Rheumatology. 2.ed. vol.1, S-4. London: Mosby, 1998; pp.16.1-16.12.
28. Jillapalli D, Shefner JM. Electrodiagnosis in common mononeuropathies and plexopathies. Semin Neurol 2005; 25 (2): 196-203.
29. Papanas N, Maltezos E. The diabetic hand: a forgotten complication? J Diabetes Complications 2010; 24(3):154-62.
30. Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002; 25 (3): 565-9.
31. Comi G, Lozza L, Galardi G, Ghilardi MF, Medaglini S, Canal N. Presence of carpal tunnel syndrome in diabetics: effects of age, sex, diabetes duration and polyneuropathy. Acta Diabetol Lat 1985; 22 (3): 259-62.
32. Geoghegan JM, Clark DI, Bainbridge LC, Smith S, Hubbard R. Risk factors in carpal tunnel syndrome. J Hand Surg Br 2004; 29 (4): 315-20.
33. Becker J, Nora DB, Gomes I, Stringari FF, Seitensus R, Panosso J et al. An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 2002; 113 (9): 1429-34.
34. McClure P. Evidence-based practice: an example related to the use of splinting in a patient with carpal tunnel syndrome. J Hand Ther 2003; 16 (3): 256-63.
35. Girlanda P, Dattola R, Venuto C, Mangiapane R, Nicolosi C, Messina C. Local steroid treatment in idiopathic carpal tunnel syndrome: short- and long-term efficacy. J Neurol 1993; 240 (3): 187-90.
36. Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003; 69 (4): 229-85.
37. Kennedy JM, Zochodne DW. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 2005; 10 (2): 144-57.
38. Tighe CB, Oakley WS Jr. The prevalence of a diabetic condition and adhesive capsulitis of the shoulder. South Med J 2008; 101 (6): 591-5.
39. Bunker TD, Anthony PP. The pathology of frozen shoulder. A Dupuytren-like disease. J Bone Joint Surg Br 1995; 77 (5): 677-83.
40. Pal B, Anderson J, Dick WC, Griffiths ID. Limitation of joint mobility and shoulder capsulitis in insulin- and non-insulindependent diabetes mellitus. Br J Rheumatol 1986; 25 (2): 147-51.
41. Balci N, Balci MK, Tüzüner S. Shoulder adhesive capsulitis and shoulder range of motion in type II diabetes mellitus: association with diabetes complications. J Diabetes Complications 1999; 13 (3): 135-40.
42. Sheridan MA, Hannafin JA. Upper extremity: emphasis on frozen shoulder. Orthop Clin North Am 2006; 37 (4): 531-9.
43. Mavrikakis ME, Drimis S, Kontoyannis DA, Rasidakis A, Moulopoulus ES, Kontoyannis S. Calcific shoulder periarthritis (tendinitis) in adult onset diabetes mellitus: a controlled study. Ann Rheum Dis 1989; 48 (3): 211-4.
44. Trujillo-Santos AJ. Diabetic muscle infarction: an underdiagnosed complication of long-standing diabetes. Diabetes Care 2003; 26 (1): 211-5.
45. Kapur S, Brunet JA, McKendry RJ. Diabetic muscle infarction: case report and review. J Rheumatol 2004; 31 (1): 190-4.
46. Kattapuram TM, Suri R, Rosol MS, Rosenberg AE, Kattapuram SV. Idiopathic and diabetic skeletal muscle necrosis: evaluation by magnetic resonance imaging. Skeletal Radiol 2005; 34 (4): 203-9.
47. Bjornskov EK, Carry MR, Katz FH, Lefkowitz J, Ringel SP. Diabetic muscle infarction: a new perspective on pathogenesis and management. Neuromuscul Disord 1995; 5 (1): 39-45.
48. Palmer GW, Greco TP. Diabetic thigh muscle infarction in association with antiphospholipid antibodies. Semin Arthritis Rheum 2001; 30 (4): 272-80.
49. Mader R, Sarzi-Puttini P, Atzeni F, Olivieri I, Pappone N, Verlaan JJ et al. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) 2009; 48 (12): 1478-81.
50. Resnick D, Niwayama G. Dish. In: Resnick D, Niwayama G (eds.). Diagnosis of bone and joint disorders. 2.ed. Philadelphia: WB Saunders, 1983; p.2436.
51. Utsinger PD. Diffuse idiopathic skeletal hyperostosis. Clin Rheum Dis 1985; 11 (2): 325-51.
52. Mader R, Dubenski N, Lavi I. Morbidity and mortality of hospitalized patients with diffuse idiopathic skeletal hyperostosis. Rheumatol Int 2005; 26 (2): 132-6.
53. Kiss C, Szilágyi M, Paksy A, Poór G. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology (Oxford) 2002; 41 (1): 27-30.
54. Sencan D, Elden H, Nacitarhan V, Sencan M, Kaptanoglu E. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheum Int 2005; 25 (7): 518-21.
55. Sarzi-Puttini P, Atzeni F. New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis). Clin Opin Rheumatol 2004; 16 (3): 287-92.
56. Giurini JM, Chrzan JS, Gibbons GW, Habershaw GM. Charcot's disease in diabetic patients. Correct diagnosis can prevent deformity. Postgrad Med 1991; 89 (4): 163-9.
57. Brower AC, Allman RM. Pathogenesis of the neurotropic joint: neurotraumatic vs. neurovascular. Radiology 1981; 139 (2): 349-54.
58. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the neuropathic osteoarthropathy: (acute Charcot foot) in diabetes. Lancet 2005; 366 (9502): 2058-61.
59. Sequeira W. The neuropathic joint. Clin Exp Rheumatol 1994; 12 (3): 325-37.
60. Fórgacs SS. Diabetes mellitus and rheumatic disease. Clin Rheum Dis 1986; 12 (3): 729-53.
61. Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology 2006; 238 (2): 622-31.
62. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994; 11(1):28-31.
63. Pitocco D, Ruotolo V, Caputo S, Mancini L, Collina CM, Manto A et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care 2005; 28 (5): 1214-5.
64. Bem R, Jirkovská A, Fejfarová V, Skibová J, Jude EB. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care 2006; 29 (6): 1392-4.
65. Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991; 49 (3): 155-60.
66. Tuominen JT, Impivaara O, Puukka P, Rönnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999; 22 (7): 1196-200.
67. DeGroot J, Verzijl N, Jakobs KM, Budde M, Bank RA, Bijlsma JW et al. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthritis Cartilage 2001; 9 (8): 720-6.
68. Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992; 22 (3): 188-202.
69. Gonzales P, Laker SR, Sullivan W, Harwood JE, Akuthota V. The effects of epidural betamethasone on blood glucose in patients with diabetes mellitus. PM R 2009; 1 (4): 340-5.
70. Even JL, Crosby CG, Song Y, McGirt MJ, Devin CJ. Effects of epidural steroid injections on blood glucose levels in patients with diabetes mellitus. Spine (Phila Pa 1976) 2012; 37(1):E46-50.
71. Wang AA, Hutchinson DT. The effect of corticosteroid injection for trigger finger on blood glucose levels in diabetic patients. J Hand Surg Am 2006; 31 (6): 979-81.
72. Habib GS, Abu-Ahmad R. Lack of effect of corticosteroid injection at the shoulder joint on blood glucose levels in diabetic patients. Clin Rheumatol 2007; 26 (4): 566-8.